Liu Y - Search Results

1

Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.

Fu P, Du F, Chen W, Yao M, Lv K, Liu Y. Fu P, et al. Among authors: liu y. Oncol Rep. 2014 Jun;31(6):2561-8. doi: 10.3892/or.2014.3140. Epub 2014 Apr 16. Oncol Rep. 2014. PMID: 24737252

2

miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.

Du F, Yu L, Wu Y, Wang S, Yao J, Zheng X, Xie S, Zhang S, Lu X, Liu Y, Chen W. Du F, et al. Among authors: liu y. Cell Death Dis. 2019 Dec 4;10(12):922. doi: 10.1038/s41419-019-2164-2. Cell Death Dis. 2019. PMID: 31801953 Free PMC article.

3

Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.

Chen YM, Liu Y, Wei HY, Lv KZ, Fu P. Chen YM, et al. Among authors: liu y. Tumour Biol. 2016 Aug;37(8):10861-70. doi: 10.1007/s13277-016-4909-1. Epub 2016 Feb 16. Tumour Biol. 2016. PMID: 26883251

4

Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells.

Chen YM, Liu Y, Wei HY, Lv KZ, Fu PF. Chen YM, et al. Among authors: liu y. Oncotarget. 2016 Sep 13;7(37):59604-59617. doi: 10.18632/oncotarget.10730. Oncotarget. 2016. PMID: 27449099 Free PMC article.

5

G15 sensitizes epithelial breast cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of GPR30.

Liu Y, Du FY, Chen W, Fu PF, Yao MY, Zheng SS. Liu Y, et al. Am J Transl Res. 2015 May 15;7(5):967-75. eCollection 2015. Am J Transl Res. 2015. PMID: 26175858 Free PMC article.

6

N1-Guanyl-1,7-Diaminoheptane Sensitizes Estrogen Receptor Negative Breast Cancer Cells to Doxorubicin by Preventing Epithelial-Mesenchymal Transition through Inhibition of Eukaryotic Translation Initiation Factor 5A2 Activation.

Liu Y, Liu R, Fu P, Du F, Hong Y, Yao M, Zhang X, Zheng S. Liu Y, et al. Among authors: liu r. Cell Physiol Biochem. 2015;36(6):2494-503. doi: 10.1159/000430209. Epub 2015 Aug 10. Cell Physiol Biochem. 2015. PMID: 26279450 Free article.

7

Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Exp Cell Res. 2013 Dec 10;319(20):3140-9. doi: 10.1016/j.yexcr.2013.08.023. Epub 2013 Sep 3. Exp Cell Res. 2013. PMID: 24012960

8

EIF5A2 is a novel chemoresistance gene in breast cancer.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Breast Cancer. 2015 Nov;22(6):602-7. doi: 10.1007/s12282-014-0526-2. Epub 2014 Mar 18. Breast Cancer. 2015. PMID: 24638963

9

WP1130 increases cisplatin sensitivity through inhibition of usp9x in estrogen receptor-negative breast cancer cells.

Fu P, Du F, Liu Y, Yao M, Zhang S, Zheng X, Zheng S. Fu P, et al. Among authors: liu y. Am J Transl Res. 2017 Apr 15;9(4):1783-1791. eCollection 2017. Am J Transl Res. 2017. PMID: 28469783 Free PMC article.

10

N1-guanyl-1, 7-diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2.

Yao M, Hong Y, Liu Y, Chen W, Wang W. Yao M, et al. Among authors: liu y. Exp Ther Med. 2017 Sep;14(3):2101-2107. doi: 10.3892/etm.2017.4740. Epub 2017 Jul 9. Exp Ther Med. 2017. PMID: 28962130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,445 results

Search Page

Filters